New drug combo tested in fight against tough pancreatic cancer
Disease control
Not yet recruiting
This study is testing a new drug called ANO31905, given along with standard chemotherapy, for people with advanced pancreatic cancer that has spread and cannot be removed by surgery. The main goals are to find a safe dose and see how well the combination works to shrink tumors. I…
Phase: PHASE1, PHASE2 • Sponsor: Anova Innovation Limited • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC